Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Semtech Corporation Common Stock (SMTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Semtech Corporation Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Semtech Corporation Common Stock trades at $187.3 (market cap $17.49B). The key difference: Semtech Corporation Common Stock is the larger of the two by market cap, and Semtech Corporation Common Stock is more actively traded (4,235,937 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Semtech Corporation Common Stock for 1 Days on average.
| HALO | SMTC | |
|---|---|---|
Market Cap | $12.58B | $17.49B |
Volume | 2,179,278 | 4,235,937 |
Sector | Health | Technology |
52-Week High | $115.22 | $197.20 |
52-Week Low | $61.63 | $62.57 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $17.78B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Semtech Corporation Common Stock
Semtech develops analog and mixed-signal semiconductors and connectivity products. Its technologies are used in communications, data centers, industrial systems, and IoT devices.
Read more on SMTC →
